Verapamil Hydrochloride Injection shortage
Verapamil Hydrochloride Injection is currently listed in shortage by the FDA. The FDA lists 1 affected product. This page was last refreshed from FDA data on Oct 5, 2026.
Pfizer is permanently stopping production of Verapamil Hydrochloride Injection 2.5 mg/mL. Other makers — including Hospira, Sagent, and Micro Labs — still list this same strength as available.
Don’t stop or change your therapy on your own — talk with your prescriber about the plan that fits you, and ask your pharmacist what’s actually available (see options).
Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →What’s in shortage — at a glance
These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Verapamil Hydrochloride Injection. Other makers that haven’t reported a problem are shown in the green card below.
Shortage timeline
-
Nov 21, 2025Currently in shortage1 of 1 product affected.
-
Nov 21, 2025First reported to the FDA1 product first listed.
Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.
What exactly is on backorder — by manufacturer
Manufacturer: Pfizer Inc. 📞 844-646-4398 1 NDC click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| To Be Discontinued | Verapamil Hydrochloride, Injection, 2.5 mg/1 mL (NDC 0409-9633-05) | — | — | Discontinuation of the manufacture of the drug | — |
These rows are manufacturer reports to the FDA for Verapamil Hydrochloride Injection — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Verapamil Hydrochloride Injection? options further down this page.
Why is Verapamil Hydrochloride Injection in shortage?
Pfizer has reported to the FDA that they are permanently stopping the manufacturing of their specific verapamil hydrochloride injection — the 2.5 mg/1 mL vial (NDC 0409-9633-05). That's why it appears on the shortage list as "to be discontinued."
It's worth knowing that Pfizer did not share a specific public reason for why they made this decision — just that they are discontinuing the manufacture of this particular product. This reflects only Pfizer's version of this injection, so it's about their product specifically, not a statement about every maker of verapamil injection out there.
Based on the manufacturer-reported reason(s) and notes on file with the FDA for Verapamil Hydrochloride Injection, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.
What should I do if I take Verapamil Hydrochloride Injection?
Verapamil Hydrochloride Injection is currently on the FDA shortage list. This is a medicine given in a clinical setting, so a care team usually manages its supply, but I want you to understand what is happening.
The only strength on this report is 2.5 mg/1 mL, and it does not have an available source from the manufacturer that filed this notice. That maker, Pfizer Inc., has listed the product as being discontinued — meaning they are stopping production of it. Because this is a discontinuation rather than a temporary delay, this particular supply problem may be permanent for that one manufacturer.
What this report does not mean is that every company has stopped making it. Several other manufacturers are listed as making the same medicine at the same 2.5 mg/mL strength.
Here is what you can do:
- Do not stop or change how this medicine is used on your own.
- Ask your pharmacy or care team to check whether the same medicine is available from another maker — several are listed, though it may not be in local stock.
- If your exact product cannot be found, ask your prescriber or pharmacist about a suitable option.
- Manufacturer contact numbers are listed on this page for reference; pharmacies usually handle those calls.
This is general, national information and may not match your local pharmacy's stock.
- Don’t stop or change the medication on your own — talk to your prescriber first.
- If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
- Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
- Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.
Where else can I get Verapamil Hydrochloride Injection?
FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Verapamil Hydrochloride Injection is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.
Same medicine, other manufacturers (not reported short)
Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:
| Product | Strength | Form / route | Manufacturer | NDC |
|---|---|---|---|---|
| Verapamil Hydrochloride | VERAPAMIL HYDROCHLORIDE 2.5 mg/mL | Injection, Solution · Intravenous | Hospira, Inc. | 00409-1144-02 |
| Verapamil Hydrochloride | VERAPAMIL HYDROCHLORIDE 2.5 mg/mL | Injection · Intravenous | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-0911-41 |
| Verapamil Hydrochloride | VERAPAMIL HYDROCHLORIDE 2.5 mg/mL | Injection, Solution · Intravenous | Sagent Pharmaceuticals | 25021-0312-02 |
| Verapamil Hydrochloride | VERAPAMIL HYDROCHLORIDE 2.5 mg/mL | Injection · Intravenous | Micro Labs Limited | 42571-0313-75 |
| Verapamil Hydrochloride | VERAPAMIL HYDROCHLORIDE 2.5 mg/mL | Injection, Solution · Intravenous | Baxter Healthcare Corporation | 43066-0031-25 |
| Verapamil Hydrochloride | VERAPAMIL HYDROCHLORIDE 2.5 mg/mL | Injection · Intravenous | EXELA PHARMA SCIENCES, LLC | 51754-0203-02 |
| Verapamil Hydrochloride | VERAPAMIL HYDROCHLORIDE 2.5 mg/mL | Injection, Solution · Intravenous | Eugia US LLC | 55150-0342-01 |
| Verapamil Hydrochloride | VERAPAMIL HYDROCHLORIDE 2.5 mg/mL | Injection, Solution · Intravenous | Caplin Steriles Limited | 65145-0113-25 |
| Verapamil Hydrochloride | VERAPAMIL HYDROCHLORIDE 2.5 mg/mL | Injection · Intravenous | FRESENIUS KABI USA, LLC | 65219-0384-02 |
| Verapamil Hydrochloride | VERAPAMIL HYDROCHLORIDE 2.5 mg/mL | Injection, Solution · Intravenous | Somerset Therapeutics, LLC | 70069-0271-05 |
| Verapamil Hydrochloride | VERAPAMIL HYDROCHLORIDE 2.5 mg/mL | Injection, Solution · Intravenous | Amneal Pharmaceuticals LLC | 70121-1585-05 |
| Verapamil Hydrochloride | VERAPAMIL HYDROCHLORIDE 2.5 mg/mL | Injection, Solution · Intravenous | REMEDYREPACK INC. | 70518-4453-00 |
Alternative dosage forms of Verapamil Hydrochloride
A different form of the same drug (for example a solution when capsules are short). A form change is a clinical decision — ask your prescriber:
Therapeutic equivalents & pricing 4 productsclick to expand
Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.
| Product | Manufacturer | Package | NADAC $/unit | AB rating | Availability |
|---|---|---|---|---|---|
| Verapamil Hydrochloride 2.5 mg/mL | Henry | 1 syringe | — | — | FDA listed |
| Verapamil Hydrochloride 2.5 mg/mL | HF | 1 syringe | — | — | FDA listed |
| Verapamil Hydrochloride 2.5 mg/mL | Zydus | 5 vials | — | AP | FDA listed |
| Verapamil Hydrochloride 2.5 mg/mL | Hospira, | 1 syringe | — | — | Discontinued |
Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.
Other drugs in the same treatment class
These are different medicines — not other versions of Verapamil Hydrochloride Injection — that fall in the same broad treatment class (calcium channel blocking agents) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.
Identity & classification
Where does this data come from?
Other cardiovascular shortages
Verapamil Hydrochloride Injection shortage FAQs
Is Verapamil Hydrochloride Injection in shortage?
Which products are affected?
When will Verapamil Hydrochloride Injection be available again?
Can I still get Verapamil Hydrochloride somewhere?
What should I do if I take Verapamil Hydrochloride Injection?
Still have a question about the Verapamil Hydrochloride Injection shortage?
Ask a pharmacist about this shortage →View Verapamil Hydrochloride Injection on the FDA drug-shortage database →
Where does this data come from?
/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.